Evidence map›Paper›PMID 39223989›Full record

ReviewImmunological reviews2024

The Janus (dual) model of immunoglobulin isotype evolution: Conservation and plasticity are the defining paradigms.

Martin F Flajnik

Abstract readReview
In one paragraph

Review in Immunological reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Martin F FlajnikDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-2792-5084

Funding

Determining the Origins of Nonclassical Class I molecules through Molecular and Functional ApproachesR01AI170844 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Erin June Adams, Martin F Flajnik · 2022 to 2026
$3.5M
Evolution of Adaptive ImmunityR01AI140326 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI FLAJNIK, MARTIN F · 2019 to 2022
$1.4M
Martin Flajnik R01AI140326Martin Flajnik R01AI170844NIAID NIH HHS R01 AI140326NIAID NIH HHS R01 AI170844
6 · The paper itself

Abstract

The study of antibodies in jawed vertebrates (gnathostomes) provides every immunologist with a bird's eye view of how human immunoglobulins (Igs) came into existence and subsequently evolved into their present forms. It is a fascinating Darwinian history of conservation on the one hand and flexibility on the other, exemplified by the Ig heavy chain (H) isotypes IgM and IgD/W, respectively. The cartilaginous fish (e.g., sharks) Igs provide a glimpse of "how everything got off the ground," while the amphibians (e.g., the model Xenopus) reveal how the adaptive immune system made an about face with the emergence of Ig isotype switching and IgG-like structure/function. The evolution of mucosal Igs is a captivating account of malleability, convergence, and conservation, and a call to arms for future study! In between there are spellbinding chronicles of antibody evolution in each class of vertebrates and rather incredible stories of how antibodies can adapt to occupy niches, for example, single-domain variable regions, cold-adapted Igs, convergent mechanisms to dampen antibody function, provision of mucosal defense, and many more. The purpose here is not to provide an encyclopedic examination of antibody evolution, but rather to hit the high points and entice readers to appreciate how things "came to be."

Indexed as

Evolution, MolecularImmunoglobulin IsotypesAdaptive ImmunityAnimalsHumansImmunoglobulin Class SwitchingImmunoglobulin IsotypesconvergenceevolutionimmunoglobulinRAG transposonvertebrates

Identifiers

PMID39223989
PMCPMC12010099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.